Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma

We initiated a prospective multicenter phase II trial using rituximab and temozolomide in immunocompetent patients with progressive or recurrent primary central nervous system lymphoma (PCNSL) based on activity observed in retrospective studies. Treatment consisted of an induction phase with rituxim...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Leuk Lymphoma
Päätekijät: Nayak, Lakshmi, Abrey, Lauren E., Drappatz, Jan, Gilbert, Mark R., Reardon, David A., Wen, Patrick Y., Prados, Michael, Deangelis, Lisa M., Omuro, Antonio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4802006/
https://ncbi.nlm.nih.gov/pubmed/22656234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2012.698736
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia